W. Akpan

471 total citations
9 papers, 384 citations indexed

About

W. Akpan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Anesthesiology and Pain Medicine. According to data from OpenAlex, W. Akpan has authored 9 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Anesthesiology and Pain Medicine. Recurrent topics in W. Akpan's work include Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Anesthesia and Sedative Agents (3 papers). W. Akpan is often cited by papers focused on Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Anesthesia and Sedative Agents (3 papers). W. Akpan collaborates with scholars based in United States, Germany and Switzerland. W. Akpan's co-authors include G. Neugebauer, K. Reiff, E von Möllendorff, Peter Neubert, B. Kaufmann, Ulrich Martin, R. Kientsch-Engel, U. Abshagen and H Jaeger and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Thrombosis and Haemostasis and European Journal of Clinical Pharmacology.

In The Last Decade

W. Akpan

9 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Akpan United States	6	182	83	81	54	50	9	384
E von Möllendorff United States	9	168 0.9×	72 0.9×	88 1.1×	61 1.1×	43 0.9×	12	430
K. Reiff United States	9	187 1.0×	130 1.6×	98 1.2×	50 0.9×	66 1.3×	16	515
B. Kaufmann Germany	14	247 1.4×	95 1.1×	68 0.8×	86 1.6×	107 2.1×	29	650
P. Collste Sweden	16	141 0.8×	104 1.3×	124 1.5×	45 0.8×	95 1.9×	24	529
R. Zacest Australia	12	224 1.2×	89 1.1×	123 1.5×	61 1.1×	114 2.3×	24	749
W. Bartsch United States	10	211 1.2×	49 0.6×	20 0.2×	64 1.2×	50 1.0×	31	441
DA Willard United States	13	140 0.8×	74 0.9×	91 1.1×	160 3.0×	118 2.4×	18	592
Stots B. Reele United States	12	367 2.0×	76 0.9×	97 1.2×	86 1.6×	73 1.5×	22	701
PA Meredith United Kingdom	14	315 1.7×	158 1.9×	69 0.9×	73 1.4×	86 1.7×	33	646
Donna Freedman United States	10	179 1.0×	28 0.3×	32 0.4×	154 2.9×	54 1.1×	13	470

Countries citing papers authored by W. Akpan

Since Specialization

Citations

This map shows the geographic impact of W. Akpan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Akpan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Akpan more than expected).

Fields of papers citing papers by W. Akpan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Akpan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Akpan. The network helps show where W. Akpan may publish in the future.

Co-authorship network of co-authors of W. Akpan

This figure shows the co-authorship network connecting the top 25 collaborators of W. Akpan. A scholar is included among the top collaborators of W. Akpan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Akpan. W. Akpan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Martin, Ulrich, et al.. (1991). Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers. Clinical Pharmacology & Therapeutics. 50(4). 429–436. 22 indexed citations

2.

Martin, Ulrich, E von Möllendorff, W. Akpan, et al.. (1991). Pharmacokinetic and Hemostatic Properties of the Recombinant Plasminogen Activator BM 06.022 in Healthy Volunteers. Thrombosis and Haemostasis. 66(5). 569–574. 45 indexed citations

3.

Neugebauer, G., W. Akpan, B. Kaufmann, & K. Reiff. (1990). Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound. European Journal of Clinical Pharmacology. 38(S2). S108–S111. 98 indexed citations

4.

Neugebauer, G., et al.. (1989). Performance of a slow-release formulation of isosorbide-5-mononitrate (ISMO retard).. PubMed. 27(1). 34–8. 2 indexed citations

5.

Neugebauer, G., W. Akpan, E von Möllendorff, Peter Neubert, & K. Reiff. (1987). Pharmacokinetics and Disposition of Carvedilol in Humans. Journal of Cardiovascular Pharmacology. 10. S85–S88. 71 indexed citations

6.

Neugebauer, G., W. Akpan, E von Möllendorff, Peter Neubert, & K. Reiff. (1987). Pharmacokinetics and Disposition of Carvedilol in Humans. Journal of Cardiovascular Pharmacology. 10. S85–S88. 1 indexed citations

7.

Neugebauer, G., W. Akpan, E von Möllendorff, Peter Neubert, & K. Reiff. (1987). Pharmacokinetics and disposition of carvedilol in humans.. PubMed. 10 Suppl 11. S85–8. 113 indexed citations

8.

Möllendorff, E von, et al.. (1986). Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activity. Clinical Pharmacology & Therapeutics. 39(6). 677–682. 27 indexed citations

9.

Neugebauer, G., W. Akpan, & U. Abshagen. (1983). [Interaction of guar with glibenclamide and bezafibrate].. PubMed. 12. 40–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact